ARMD.MultS {Surrogate} | R Documentation |
Data of the Age-Related Macular Degeneration Study with multiple candidate surrogates
Description
These are the data of a clinical trial involving patients suffering from age-related macular degeneration (ARMD), a condition that involves a progressive loss of vision. A total of 181
patients participated in the trial. Patients' visual acuity was assessed using standardized vision charts. There were two treatment conditions (placebo and interferon-\alpha
). The potential surrogate endpoints are the changes in the visual acuity at 4
, 12
, and 24
weeks after starting treatment. The true endpoint is the change in the visual acuity at 52
weeks.
Usage
data(ARMD.MultS)
Format
A data.frame
with 181
observations on 6
variables.
Id
The Patient ID.
Diff4
The change in the visual acuity at
4
weeks after starting treatment. This endpoint is a potential surrogate forDiff52
.Diff12
The change in the visual acuity at
12
weeks after starting treatment. This endpoint is a potential surrogate forDiff52
.Diff24
The change in the visual acuity at
24
weeks after starting treatment. This endpoint is a potential surrogate forDiff52
.Diff52
The change in the visual acuity at
52
weeks after starting treatment. This outcome serves as the true endpoint.Treat
The treatment indicator, coded as
-1
= placebo and1
= interferon-\alpha
.